Phospho-EPS15 (Y849) Antibody

What is Phospho-EPS15 (Y849) Antibody and what epitope does it recognize?

Phospho-EPS15 (Y849) Antibody is an immunological reagent specifically designed to detect endogenous levels of the EPS15 protein only when phosphorylated at tyrosine residue 849. The antibody is typically generated using a synthesized phospho-peptide derived from human EPS15 protein around the phosphorylation site of Y849 . This specificity allows researchers to monitor the phosphorylation state of EPS15 at this particular residue, which is critically involved in receptor-mediated endocytosis processes. The antibody does not recognize unphosphorylated EPS15 or EPS15 phosphorylated at other sites, making it a valuable tool for studying specific signaling events involving this phosphorylation site .

What is the biological significance of EPS15 Y849 phosphorylation?

Phosphorylation of EPS15 at tyrosine 849 plays a crucial role in the internalization of Epidermal Growth Factor Receptor (EGFR). According to research findings, this specific phosphorylation event is not required for the initial membrane translocation of EPS15 after EGF treatment or for its targeting to coated pits. Instead, it is essential for a subsequent step in EGFR endocytosis . This phosphorylation represents a key regulatory mechanism in receptor-mediated endocytosis pathways, particularly for receptor tyrosine kinases. Understanding this modification helps researchers elucidate how cells regulate the trafficking of growth factor receptors, which has implications for normal cell growth, cancer development, and potential therapeutic interventions targeting endocytic pathways .

What are the common applications for Phospho-EPS15 (Y849) Antibody?

The primary applications for Phospho-EPS15 (Y849) Antibody include:

• Western Blot (WB): Typically used at dilutions of 1:500-1:2000 to detect the phosphorylated protein in cell or tissue lysates

• ELISA: Generally used at dilutions around 1:10000 for quantitative detection

While these represent the validated applications, the antibody has potential utility in other immunological techniques that haven't been extensively tested yet, such as immunoprecipitation, immunohistochemistry, or immunofluorescence microscopy. The observed band size in Western blot applications is approximately 100 kDa, which corresponds to the expected molecular weight of the phosphorylated EPS15 protein .

How should researchers optimize Western blot conditions for Phospho-EPS15 (Y849) Antibody?

For optimal Western blot results with Phospho-EPS15 (Y849) Antibody, researchers should consider the following protocol optimizations:

• Sample preparation: Ensure preservation of phosphorylation status by including phosphatase inhibitors in lysis buffers.

• Protein loading: Load 20-50 μg of total protein per lane.

• Dilution optimization: Begin with the manufacturer's recommended dilution range (1:500-1:2000) and adjust based on signal intensity.

• Blocking conditions: Use 5% BSA in TBST rather than milk-based blockers, as milk contains phosphatases that might reduce signal.

• Incubation time: Optimal primary antibody incubation is typically overnight at 4°C.

• Controls: Include both phosphorylated (EGF-stimulated cells) and dephosphorylated (phosphatase-treated or unstimulated) samples to confirm specificity.

Researchers should note that the antibody specifically detects the 100 kDa band corresponding to phosphorylated EPS15 . Validation experiments have confirmed that the signal increases after treatments known to induce receptor tyrosine kinase activation, such as EGF stimulation.

What cell stimulation protocols effectively induce EPS15 Y849 phosphorylation?

To effectively induce phosphorylation of EPS15 at tyrosine 849 for experimental studies, researchers should consider these established protocols:

The JK cell line has been successfully used to demonstrate phosphorylation of EPS15 at Y849 and can serve as a positive control in Western blot experiments . For comparing different treatment conditions, high-throughput microscopy combined with phospho-specific antibody staining has proven effective for quantitative analysis of phosphorylation events .

What are the recommended storage and handling conditions for maintaining antibody activity?

To preserve the functionality and specificity of Phospho-EPS15 (Y849) Antibody over time, the following storage and handling practices are recommended:

• Long-term storage: Store at -20°C or -80°C, as specified by the manufacturer . Most formulations maintain stability for up to one year when properly stored.

• Working aliquots: Upon receipt, divide the antibody into small single-use aliquots before freezing to avoid repeated freeze-thaw cycles, which can significantly degrade antibody performance .

• Formulation considerations: The antibody is typically supplied in PBS containing 50% glycerol, 0.5% BSA, and 0.02% sodium azide . This formulation helps maintain stability during freeze-thaw transitions.

• Thawing procedure: Thaw aliquots completely at room temperature or 4°C before use, and mix gently by inversion rather than vortexing to avoid protein denaturation.

• Working dilution stability: Once diluted for use, the antibody remains stable for approximately 1 week when stored at 4°C. For extended experiments, prepare fresh working dilutions.

• Contamination prevention: Use sterile technique when handling the antibody to prevent microbial contamination, which can degrade the protein and introduce experimental artifacts.

How can Phospho-EPS15 (Y849) Antibody be used to investigate endocytic trafficking pathways?

The Phospho-EPS15 (Y849) Antibody serves as a powerful tool for investigating endocytic trafficking pathways, particularly those involving receptor tyrosine kinases. Advanced research applications include:

• Temporal dynamics analysis: Using time-course experiments with EGF stimulation followed by immunoblotting with the phospho-specific antibody allows researchers to track the timing of EPS15 phosphorylation relative to receptor internalization events . This approach can be extended to study how different ligands or drug treatments affect endocytic kinetics.

• Co-localization studies: Combining the phospho-specific antibody with immunofluorescence microscopy enables visualization of where phosphorylated EPS15 localizes within the cell during endocytosis. EPS15 has been shown to localize to clathrin-coated pits and is recruited to the plasma membrane upon EGFR activation . This allows researchers to track the dynamic redistribution of active EPS15 during receptor trafficking.

• Interaction partner identification: Using the phospho-specific antibody for immunoprecipitation followed by mass spectrometry can identify proteins that specifically interact with the phosphorylated form of EPS15, providing insights into phosphorylation-dependent protein complexes involved in endocytosis.

• High-throughput screening: As demonstrated in recent studies, high-throughput microscopy combined with machine learning approaches can be employed to assess how different compounds affect EPS15 phosphorylation status and subsequent endocytic events . This methodology enables screening of potential modulators of endocytic trafficking with high specificity.

How can researchers validate the specificity of phospho-EPS15 signal in their experimental system?

Validating the specificity of the phospho-EPS15 (Y849) signal is crucial for experimental rigor. Advanced researchers should implement multiple validation strategies:

• Genetic validation: Use of EPS15 knockout or knockdown cells provides the gold standard for antibody validation. Complete absence of signal in these cells confirms antibody specificity. This approach aligns with recommendations from the International Working Group for Antibody Validation (IWGAV) .

• Phosphatase treatment control: Treating cell lysates with lambda phosphatase before immunoblotting should abolish signal from a truly phospho-specific antibody.

• Competing peptide assay: Pre-incubating the antibody with excess phosphorylated peptide (the immunogen) should block specific binding, while pre-incubation with the corresponding non-phosphorylated peptide should not affect binding.

• Mutational analysis: Express wild-type EPS15 alongside a Y849F mutant (which cannot be phosphorylated at this site) and demonstrate selective detection of only the wild-type protein after stimulation.

• Orthogonal method comparison: Compare results from multiple antibodies targeting different epitopes in the same protein to assess consistency . Additionally, phosphoproteomic mass spectrometry can serve as an antibody-independent method to confirm the phosphorylation state.

• High-throughput microscopy platform: Implement automated image analysis with software such as CellProfiler to quantitatively assess antibody specificity across different experimental conditions, as described in recent methodological developments .

How does EPS15 phosphorylation correlate with different receptor tyrosine kinase signaling pathways?

The correlation between EPS15 phosphorylation and different receptor tyrosine kinase (RTK) signaling pathways reveals important regulatory mechanisms in endocytosis. Advanced studies should consider:

• Differential kinetics: While EPS15 Y849 phosphorylation is well-established in EGFR signaling, its phosphorylation kinetics may differ between various RTKs. For example, studies of temporal dynamics have revealed differences in phosphorylation patterns between different opioid receptor activators like morphine and fentanyl , suggesting EPS15 may similarly show ligand-specific phosphorylation patterns across RTK systems.

• Pathway specificity: Researchers should determine whether EPS15 Y849 phosphorylation is specific to certain RTK pathways or represents a common mechanism across multiple receptor systems. This can be assessed by stimulating cells with different growth factors (EGF, PDGF, FGF, IGF, etc.) and comparing the resulting phosphorylation patterns.

• Phosphorylation site specificity: While Y849 phosphorylation is involved in EGFR internalization, EPS15 contains multiple phosphorylation sites. For instance, EPS15 can also be phosphorylated on serine residues in response to DNA damage, likely by ATM or ATR kinases . Understanding how these different phosphorylation events interact and potentially cross-regulate one another provides insight into the integration of diverse cellular signals.

• Functional consequences: Researchers should investigate how phosphorylation at Y849 affects EPS15's interaction with other endocytic proteins like AP-2, clathrin, and ubiquitin. Phosphorylation may alter protein-protein interaction networks in a receptor-specific manner.

What are the common sources of background or non-specific signals when using Phospho-EPS15 (Y849) Antibody?

When working with Phospho-EPS15 (Y849) Antibody, researchers may encounter several sources of background or non-specific signals. Addressing these issues requires understanding their origins:

• Insufficient blocking: Inadequate blocking can lead to non-specific binding. Use 5% BSA in TBST for at least 1 hour at room temperature, or overnight at 4°C for reduced background.

• Cross-reactivity with related phosphorylation sites: While the antibody is designed to be specific for Y849, phosphorylation motifs may be conserved across proteins. Verify specificity through knockout controls and peptide competition assays .

• Degraded samples: Phosphorylation status can be lost during sample preparation. Always include phosphatase inhibitors (sodium orthovanadate, sodium fluoride, β-glycerophosphate) in lysis buffers and keep samples cold throughout processing.

• Suboptimal antibody concentration: Too high antibody concentration increases background. Titrate the antibody within the recommended range (1:500-1:2000 for WB) to determine optimal signal-to-noise ratio.

• Secondary antibody issues: Non-specific binding of secondary antibodies can contribute to background. Include a secondary-only control and consider using secondary antibodies pre-adsorbed against the species of your samples.

• Detection system sensitivity: Overly sensitive detection reagents may amplify weak non-specific interactions. Adjust exposure times or switch to less sensitive detection methods if background is problematic.

What positive and negative controls should be incorporated when studying EPS15 phosphorylation?

Robust experimental design for studying EPS15 phosphorylation requires appropriate controls:

Positive Controls:

• EGF-stimulated cells: Cells treated with EGF (50-100 ng/ml for 5-15 minutes) reliably induce EPS15 Y849 phosphorylation .

• JK cell lysates: This cell line has been documented to show detectable levels of phosphorylated EPS15 and can serve as a technical positive control .

• Cells overexpressing wild-type EPS15: These provide an amplified signal that can help establish the correct molecular weight band.

Negative Controls:

• EPS15 knockout/knockdown cells: The complete absence of signal validates antibody specificity .

• Phosphatase-treated lysates: Treatment with lambda phosphatase should eliminate phospho-specific signals.

• Y849F mutant EPS15: This phospho-deficient mutant should not be detected by the phospho-specific antibody after stimulation.

• Unstimulated/serum-starved cells: Cells with minimal receptor tyrosine kinase activity typically show reduced EPS15 phosphorylation.

• Blocking peptide competition: Pre-incubation of the antibody with the phosphorylated immunogenic peptide should abolish specific signals.

Using these controls in combination provides multiple layers of validation, enhancing confidence in experimental findings related to EPS15 phosphorylation dynamics.

How can researchers quantify changes in EPS15 phosphorylation levels accurately?

Accurate quantification of EPS15 phosphorylation requires rigorous methodological approaches:

• Normalization strategies:

  • Total protein normalization: Use stain-free gels or total protein stains (SYPRO Ruby, Coomassie) as loading controls rather than housekeeping proteins, which may vary across conditions.

  • Ratio to total EPS15: Probe parallel blots or strip and reprobe with an antibody against total EPS15 to calculate phospho/total ratios, which accounts for variations in EPS15 expression levels.

• Quantitative imaging protocols:

  • Use a calibrated digital imaging system with a linear dynamic range.

  • Avoid saturated signals, as these prevent accurate quantification.

  • Perform multiple independent biological replicates (n≥3) for statistical validity.

  • Apply consistent exposure settings across all comparable samples.

• Advanced quantification methods:

  • High-throughput microscopy coupled with machine learning analysis provides an unbiased, reproducible method for quantifying phosphorylation signals at the single-cell level .

  • This approach allows identification of subtle changes in phosphorylation patterns and can detect cell-to-cell variability that might be masked in population-based assays.

• Statistical analysis recommendations:

  • Use appropriate statistical tests based on data distribution (parametric vs. non-parametric).

  • Control for multiple comparisons when assessing changes across numerous conditions.

  • Report effect sizes and confidence intervals, not just p-values.

• Validation through orthogonal methods:

  • Confirm key findings using alternative techniques such as mass spectrometry-based phosphoproteomics, which can provide absolute quantification of phosphorylation stoichiometry.

How does phosphorylation of EPS15 at Y849 compare with other post-translational modifications of this protein?

EPS15 undergoes several post-translational modifications that regulate its function in different cellular contexts. A comparative analysis reveals:

Phosphorylation at Y849 is specifically involved in receptor-mediated endocytosis pathways, particularly for EGFR internalization . This modification is not required for the initial membrane translocation of EPS15 after EGF treatment or for targeting to coated pits, but it is essential for subsequent steps in EGFR endocytosis .

In contrast, serine phosphorylation of EPS15 occurs in response to DNA damage, likely mediated by ATM or ATR kinases . This represents a distinct regulatory mechanism linking EPS15 function to cellular stress responses rather than receptor trafficking.

Ubiquitination of EPS15 adds another layer of regulation, affecting its protein-protein interactions and potentially its subcellular localization. EPS15 colocalizes with UBQLN1 in ubiquitin-rich cytoplasmic aggregates , suggesting complex interplay between these post-translational modifications.

Understanding the specific roles of each modification helps researchers interpret experimental results in the proper biological context and design targeted interventions to modulate specific aspects of EPS15 function.

What is known about the role of EPS15 Y849 phosphorylation in pathological conditions?

The role of EPS15 Y849 phosphorylation in pathological conditions reveals important connections between endocytic trafficking and disease processes:

• Cancer implications:

  • Dysregulation of EGFR endocytosis is implicated in various cancers, and as a key mediator of this process, EPS15 phosphorylation status may influence tumor progression.

  • EPS15 is involved in chromosomal aberrations found in acute leukemias, specifically translocation t(1;11)(p32;q23) with MLL/HRX, resulting in a rogue activator protein . While the direct relationship between this translocation and Y849 phosphorylation remains unclear, altered phosphorylation could potentially affect oncogenic signaling.

• Neurological disorders:

  • Proper receptor trafficking is critical in neuronal function, and dysregulated endocytosis has been implicated in various neurological conditions.

  • Recent studies using high-throughput antibody validation approaches have begun examining synaptic protein phosphorylation in neuronal signaling contexts , suggesting potential roles for EPS15 phosphorylation in synaptic plasticity.

• Therapeutic targeting potential:

  • Understanding the specific role of Y849 phosphorylation could reveal new therapeutic targets.

  • Compounds that selectively modulate this phosphorylation event might offer precise control over receptor downregulation pathways, potentially useful in conditions with aberrant receptor signaling.

• Biomarker potential:

  • Altered phosphorylation patterns of endocytic proteins like EPS15 could serve as biomarkers for diseases characterized by dysregulated receptor trafficking.

  • Phospho-specific antibodies enable potential diagnostic applications through techniques like immunohistochemistry or phosphoproteomic profiling.

Further research is needed to fully elucidate the role of EPS15 Y849 phosphorylation in specific disease contexts, and phospho-specific antibodies represent essential tools for these investigations.

What emerging techniques might enhance the study of EPS15 phosphorylation dynamics?

The study of EPS15 phosphorylation dynamics stands to benefit significantly from several emerging techniques:

• Live-cell phosphorylation sensors:

  • Genetically encoded FRET-based biosensors incorporating the EPS15 phosphorylation motif could enable real-time visualization of phosphorylation events in living cells.

  • This approach would overcome the limitations of antibody-based detection, which requires cell fixation and provides only static snapshots of dynamic processes.

• High-resolution spatial mapping:

  • Super-resolution microscopy techniques (STORM, PALM, STED) combined with phospho-specific antibodies can map the nanoscale distribution of phosphorylated EPS15 relative to endocytic structures.

  • Correlative light and electron microscopy (CLEM) would link phosphorylation status to ultrastructural features of endocytic intermediates.

• Single-cell phosphoproteomics:

  • Emerging mass spectrometry approaches for single-cell analysis could reveal cell-to-cell variability in EPS15 phosphorylation responses.

  • This would address the limitations of population-based measurements that mask heterogeneity in cellular responses.

• CRISPR-based phosphorylation site editing:

  • Precise genome editing to introduce phosphomimetic (Y849E/D) or phosphodeficient (Y849F) mutations at endogenous loci would allow examination of phosphorylation effects without overexpression artifacts.

  • Base editing approaches offer even more subtle manipulation of phosphorylation sites.

• Integrated multi-omics approaches:

  • Combining phosphoproteomics with interaction proteomics and transcriptomics can reveal how EPS15 phosphorylation coordinates broader cellular responses.

  • High-throughput microscopy coupled with machine learning, as demonstrated in recent studies , can quantitatively assess these events at scale.

These emerging approaches promise to deepen our understanding of the temporal and spatial dynamics of EPS15 phosphorylation in the context of receptor trafficking and cellular signaling.